T. Rowe Price Associates’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-866,703
Closed -$1.33M 3064
2021
Q4
$1.33M Sell
866,703
-2,400
-0.3% -$3.96K ﹤0.01% 1879
2021
Q3
$1.36M Sell
869,103
-65,400
-7% -$128K ﹤0.01% 1888
2021
Q2
$2.46M Buy
934,503
+10,545
+1% +$19.6K ﹤0.01% 1668
2021
Q1
$1.4M Buy
923,958
+65,400
+8% +$113K ﹤0.01% 1880
2020
Q4
$1.12M Hold
858,558
﹤0.01% 1887
2020
Q3
$970K Hold
858,558
﹤0.01% 1804
2020
Q2
$713K Sell
858,558
-6,422
-0.7% -$4.77K ﹤0.01% 1925
2020
Q1
$625K Hold
864,980
﹤0.01% 1884
2019
Q4
$1.15M Buy
864,980
+4,066
+0.5% +$5.67K ﹤0.01% 1834
2019
Q3
$1.21M Sell
860,914
-267,179
-24% -$533K ﹤0.01% 1732
2019
Q2
$3.64M Buy
1,128,093
+671
+0.1% +$2.31K ﹤0.01% 1441
2019
Q1
$4.23M Buy
1,127,422
+630,698
+127% +$2M ﹤0.01% 1421
2018
Q4
$1.08M Buy
496,724
+169
+0% +$419 ﹤0.01% 1766
2018
Q3
$1.34M Buy
+496,555
New +$1.75M ﹤0.01% 1749
2016
Q3
Sell
-14,000
Closed -$55K 2574
2016
Q2
$55K Hold
14,000
﹤0.01% 2475
2016
Q1
$47K Hold
14,000
﹤0.01% 2471
2015
Q4
$60K Sell
14,000
-1,663,273
-99% -$7.14M ﹤0.01% 2464
2015
Q3
$7.04M Sell
1,677,273
-971,150
-37% -$6.13M ﹤0.01% 1383
2015
Q2
$21.6M Hold
2,648,423
﹤0.01% 1112
2015
Q1
$20.6M Sell
2,648,423
-719,747
-21% -$6.16M ﹤0.01% 1124
2014
Q4
$39.4M Sell
3,368,170
-148,087
-4% -$1.77M 0.01% 920
2014
Q3
$45.5M Sell
3,516,257
-570,888
-14% -$7.53M 0.01% 862
2014
Q2
$59.6M Sell
4,087,145
-126,000
-3% -$2.05M 0.01% 807
2014
Q1
$85.9M Buy
+4,213,145
New +$122M 0.02% 681

T. Rowe Price Associates's CSLT Position: Q1 2022 in Review

T. Rowe Price Associates sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 866,703 shares — an estimated $1.33M sold.

T. Rowe Price Associates first reported a position in CSLT in Q1 2014 and held it in 24 quarters. The position peaked at $85.9M in Q1 2014. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • T. Rowe Price Associates reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 866,703 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $1.33M.
  • T. Rowe Price Associates first reported a position in CASTLIGHT HEALTH, INC. in Q1 2014 and held it in 24 quarters.
  • T. Rowe Price Associates's CASTLIGHT HEALTH, INC. position peaked at $85.9M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.